Akums Drugs & Pharmaceuticals Enterprise Value (EV)

Akums Drugs & Pharmaceuticals Ltd Enterprise Value

The Akums Drugs & Pharmaceuticals Ltd Enterprise Value is a key financial metric used by investors to evaluate Akums Drugs & Pharmaceuticals Ltd's valuation, profitability, and overall financial performance. Tracking the Akums Drugs & Pharmaceuticals Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Akums Drugs & Pharmaceuticals Ltd (NSE: AKUMS, BSE: 544222) is currently trading at ₹527.90, with a market capitalization of ₹85.14B. As a leading company in the Health technology sector and Biotechnology industry, monitoring the Akums Drugs & Pharmaceuticals Ltd Enterprise Value is essential for fundamental analysis.

Akums Drugs & Pharmaceuticals Ltd Enterprise Value Current Value

The current Akums Drugs & Pharmaceuticals Ltd Enterprise Value stands at 66.29B.

The latest Akums Drugs & Pharmaceuticals Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.

Akums Drugs & Pharmaceuticals Ltd Enterprise Value Historical Trend

The Akums Drugs & Pharmaceuticals Ltd Enterprise Value has shown the following historical trend:

• 2024: 66.29B
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The recent rise in Akums Drugs & Pharmaceuticals Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.

What Akums Drugs & Pharmaceuticals Ltd Enterprise Value Indicates for Investors

The Akums Drugs & Pharmaceuticals Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.

This ratio is an important metric used in fundamental analysis of Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd Enterprise Value Analysis Summary

The Akums Drugs & Pharmaceuticals Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Akums Drugs & Pharmaceuticals Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Akums Drugs & Pharmaceuticals Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.